We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUNE
2701
DELISTED
SUNEDISON, INC COM
SUNE
– –
-5
Closed –
ATLS
2702
DELISTED
ATLAS ENERGY GRP,LLC COM UNITS REPSTG LTD (DE)
ATLS
$0 ﹤0.01%
14,625
– –
IEH
2703
DELISTED
INTEGRYS ENERGY GROUP INC 6% JR SUB NT DUE 8-1-2073 (WI)
IEH
$0 ﹤0.01%
33
– –
ZGNX
2704
DELISTED
Zogenix, Inc.
ZGNX
– –
-36
Closed -$1
CPY
2705
DELISTED
C P I CORP
CPY
$0 ﹤0.01%
579
– –
FCFL
2706
DELISTED
FIRST COMMUNITY BANK CORP OF AMERICA (FL) COM STK
FCFL
$0 ﹤0.01%
1,653
– –
FNM
2707
DELISTED
FANNIE MAE
FNM
$0 ﹤0.01%
100
– –
LRT
2708
DELISTED
LL&E ROYALTY TR UTS BI
LRT
$0 ﹤0.01%
250
– –
QGP
2709
DELISTED
Quantum Group, Inc. (The) New Common Stock
QGP
$0 ﹤0.01%
7,500
– –
WRSP
2710
DELISTED
WORLDSPACE, INC.
WRSP
$0 ﹤0.01%
35
– –
PDLI
2711
DELISTED
PDL BioPharma, Inc.
PDLI
$0 ﹤0.01%
206
– –
YELL
2712
DELISTED
Yellow Corporation Common Stock
YELL
– –
-224
Closed –
BBL
2713
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
– –
-151
Closed -$6
VVUS
2714
DELISTED
Vivus Inc
VVUS
– –
-250
Closed –
FTR
2715
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
580
-19
-3% -$15
CELG
2716
DELISTED
Celgene Corp
CELG
– –
-1,228,287
Closed -$122K
ESNC
2717
DELISTED
EnSync Inc
ESNC
– –
-36,070
Closed –
ARLZ
2718
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
– –
-16,000
Closed –
RTK
2719
DELISTED
Rentech, Inc.
RTK
$0 ﹤0.01%
113
– –
UTA
2720
DELISTED
Universal Travel Group New Common Stock
UTA
$0 ﹤0.01%
2,500
– –
FNSR
2721
DELISTED
Finisar Corp
FNSR
– –
-161
Closed -$3
GCI
2722
DELISTED
Gannett Co., Inc
GCI
– –
-955
Closed -$10
LFT
2723
DELISTED
LONGTOP FINL TECHNOLOGIES LTD ADS (CAYMAN ISLANDS)
LFT
$0 ﹤0.01%
155
– –
SPN
2724
DELISTED
Superior Energy Services, Inc.
SPN
$0 ﹤0.01%
41
-1
-2% -$5
105 106 107 108
109

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.